Mutant Strain
Mutant Strain - Related Videos
03:03
Phenotypic Comparison of Wild-Type and Mutant Strains of Streptomyces coelicolor
0 Views •
2025
Source: Bennett, J. A., et al. Visual and Microscopic Evaluation of Streptomyces Developmental Mutants. J. Vis. Exp. (2018)This video demonstrates the cultivation and phenotypic comparison of wild-type and mutant Streptomyces coelicolor strains. It outlines procedures for minimizing spontaneous mutations, preventing cross-contamination, and promoting bacterial growth through proper plating techniques. Finally, the video highlights visual differences in colony morphology to illustrate the...
06:06
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
0 Views •
Cited by 2 •
2020
Here, we describe a S. pneumoniae serotype 1 strain 519/43 that can be genetically modified by using its ability to naturally acquire DNA and a suicide-plasmid. As proof of principle, an isogenic mutant in the pneumolysin (ply) gene was made.
11:35
Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
0 Views •
Cited by 6 •
2018
Pseudomonas aeruginosa infection causes significant morbidity in vulnerable hosts. The nonredundant transposon insertion mutant library of P. aeruginosa strain PA14, designated as PA14NR Set, facilitates analysis of gene functionality in numerous processes. Presented here is a protocol to generate high-quality copies of the PA14NR Set mutant library.
02:58
Measurement of Compressive Stress-Strain Response at Small-Strains
0 Views •
2025
This protocol presents the configuration of a compression test device capable of precisely measuring the mechanical properties of microstructures in the small-strain region, along with a systematic method for compression testing using this device. The proposed device can be used to analyze various microstructures and the mechanical behavior of polymer-based materials.
11:45
Generation of Marked and Markerless Mutants in Model Cyanobacterial Species
0 Views •
Cited by 36 •
2016
Introducing multiple genomic alterations into cyanobacteria is an essential tool in the development of strains for industrial and basic research purposes. We describe a system for generating unmarked mutants in the model cyanobacterial species Synechocystis sp. PCC6803 and marked mutants in Synechococcus sp. PCC7002.
FAQs
The most informative comparison links a genetic change with a measurable difference from the parental strain. Researchers can examine altered gene expression, protein function, growth, antigen production, immune susceptibility, or antimicrobial susceptibility. When these differences occur alongside the mutation, the strain provides evidence about how that genetic change may influence microbial behavior or interactions with the host.
The parental strain provides the reference point needed to interpret changes in the mutant strain. Comparing both populations helps distinguish traits associated with the genetic alteration from characteristics already present in the original microorganism or cell population. This comparison is especially important when evaluating growth, antigen production, immune responses, or susceptibility to antimicrobial agents.
A mutation may change gene expression, protein function, or antigen production, which can modify how immune defenses respond to the microorganism or cell. It may also alter susceptibility to antimicrobial agents. Measuring these outcomes helps connect genetic variation with functional changes and can identify traits that influence the effectiveness of immune protection or treatment.
Comparing strains can show how genetic variation is associated with transmission, disease severity, or other clinically important traits. A mutant strain may help researchers examine whether a particular change affects interactions with the host or alters a factor related to infection. These comparisons also support investigation of how important traits emerge among circulating or experimentally studied strains.
A comparison begins by examining the mutant and parental strains under the relevant study conditions. Researchers then assess supported outcomes such as growth, gene expression, protein function, antigen production, immune responses, or antimicrobial susceptibility. Interpreting the differences together allows the genetic change to be connected with altered biological behavior, host interaction, or treatment response.
Mutant strains are useful when researchers need to determine whether a genetic feature contributes to infection-related behavior. Comparing the mutant with its parental strain can reveal changes associated with host interactions, immune responses, growth, or disease severity. This approach helps identify candidate virulence factors, meaning features that may contribute to the ability to cause or sustain infection.
Differences in antigen production, immune susceptibility, or antimicrobial susceptibility can highlight features relevant to prevention and treatment. If a genetic change alters an antigen or affects the response to immune defenses, the comparison may clarify its potential importance for vaccine research. Changes involving antimicrobial susceptibility can similarly inform assessment of therapeutic targets.
These analyses connect genetic variation with measurable infection-related outcomes. They can clarify pathogen-host interactions, define virulence factors, evaluate immune responses, and examine traits linked with transmission or disease severity. By comparing mutant and parental strains, researchers also gain context for understanding how clinically important characteristics emerge and why different strains may produce different experimental or clinical outcomes.